Last 12 months
Inside the activity.
1 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2021 Filed Mar 9, 2021 01:38 UTC |
Potti ManishDirector
|
Exercise / conversionOprion (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000224 · edgar.xml · derivative · entry 5 Potti Manish · CIK 0001797537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,000 Underlying: Common Stock · 7,000 shares Expires 2031-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through January 1, 2024, subject to the Reporting Person's continued service with the Company through each such date. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 01:38 UTC |
Potti ManishDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-21-000224 · edgar.xml · derivative · entry 4 Potti Manish · CIK 0001797537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 21,000 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the second day of each month through January 2, 2023, subject to the Reporting Person's continued service with the Company through each such date. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 01:38 UTC |
Potti ManishDirector
|
Exercise / conversionCommon Stock | 7,000 | $1.83 | $12,810.00 |
DisclosureSEC source: 0001192482-21-000224 · edgar.xml · nonDerivative · entry 2 Potti Manish · CIK 0001797537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 01:38 UTC |
Potti ManishDirector
|
Exercise / conversionCommon Stock | 21,000 | $0.51 | $10,710.00 |
DisclosureSEC source: 0001192482-21-000224 · edgar.xml · nonDerivative · entry 1 Potti Manish · CIK 0001797537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 22:31 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 35,591 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-21-000125 · edgar.xml · derivative · entry 2 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,183 Underlying: Common Stock · 35,591 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options to purchase one third of the shares (35,591 shares of common stock) vested on January 2, 2021. The remaining options will vest annually in equal installments on January 2, 2022 and January 2, 2023, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 22:31 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionCommon Stock | 35,591 | $0.51 | $18,151.41 |
DisclosureSEC source: 0001192482-21-000125 · edgar.xml · nonDerivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2021 Filed Jan 4, 2021 22:37 UTC |
Castillo KirstenDirector
|
GrantOption (Right to Buy) · Derivative | 126,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000017 · edgar.xml · derivative · entry 1 Castillo Kirsten · CIK 0001808806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2031-01-01 F1 · derivative.exercise_date: The option vests monthly in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 01, 2021 Filed Jan 4, 2021 22:50 UTC |
Tammara VijaySenior Vice President
|
GrantOption (Right to Buy) · Derivative | 220,500 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000025 · edgar.xml · derivative · entry 1 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,500 Underlying: Common Stock · 220,500 shares Expires 2031-01-01 F1 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 1, 2022, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| January 01, 2021 Filed Jan 4, 2021 22:49 UTC |
Kompella UdayDirector
|
GrantOption (Right to Buy) · Derivative | 126,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000024 · edgar.xml · derivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2031-01-01 F1 · derivative.exercise_date: The option vests monthly in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 01, 2021 Filed Jan 4, 2021 22:47 UTC |
Taspolatoglu SuhaDirector
|
GrantOption (Right to Buy) · Derivative | 126,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000023 · edgar.xml · derivative · entry 1 Taspolatoglu Suha · CIK 0001790351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2031-01-01 F1 · derivative.exercise_date: The option vests monthly in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 01, 2021 Filed Jan 4, 2021 22:47 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
GrantOption (Right to Buy) · Derivative | 1,757,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000022 · edgar.xml · derivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,757,000 Underlying: Common Stock · 1,757,000 shares Expires 2031-01-01 F1 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 1, 2022, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| January 01, 2021 Filed Jan 4, 2021 22:44 UTC |
Subramanian SanjayChief Financial Officer
|
GrantOption (Right to Buy) · Derivative | 800,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000021 · edgar.xml · derivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2031-01-01 F1 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 1, 2022, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| January 01, 2021 Filed Jan 4, 2021 22:43 UTC |
Kumar RameshDirector
|
GrantOption (Right to Buy) · Derivative | 126,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000020 · edgar.xml · derivative · entry 1 Kumar Ramesh · CIK 0001580074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2031-01-01 F1 · derivative.exercise_date: The option vests monthly in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 01, 2021 Filed Jan 4, 2021 22:41 UTC |
Fernandes PrabhavathiDirector
|
GrantOption (Right to Buy) · Derivative | 126,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000019 · edgar.xml · derivative · entry 1 Fernandes Prabhavathi · CIK 0001540883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2031-01-01 F1 · derivative.exercise_date: The option vests monthly in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 01, 2021 Filed Jan 4, 2021 22:39 UTC |
Potti ManishDirector
|
GrantOption (Right to Buy) · Derivative | 126,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000018 · edgar.xml · derivative · entry 1 Potti Manish · CIK 0001797537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2031-01-01 F1 · derivative.exercise_date: The option vests monthly in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 01, 2021 Filed Jan 4, 2021 22:26 UTC |
Zhang JungeDirector
|
GrantOption (Right to Buy) · Derivative | 126,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001192482-21-000011 · edgar.xml · derivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2031-01-01 F1 · derivative.exercise_date: The option vests monthly in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 23:55 UTC |
Tammara VijaySenior Vice President
|
GrantOptions (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001192482-20-000676 · edgar.xml · derivative · entry 1 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-08-14 F1 · derivative.exercise_date: The options will vest in equal monthly installments over three years commencing on August 14, 2020, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| May 28, 2020 Filed May 29, 2020 22:48 UTC |
Castillo KirstenDirector
|
PurchaseCommon Stock | 75,000 | $0.31 | $23,497.50 |
DisclosureSEC source: 0001192482-20-000414 · edgar.xml · nonDerivative · entry 1 Castillo Kirsten · CIK 0001808806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Read SEC document |
| May 07, 2020 Filed May 8, 2020 00:01 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
GrantOptions (Right to Buy) · Derivative | 1,357,145 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001192482-20-000331 · edgar.xml · derivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,357,145 Underlying: Common Stock · 1,357,145 shares Expires 2030-05-07 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on May 7, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| May 05, 2020 Filed May 7, 2020 23:58 UTC |
Subramanian SanjayChief Financial Officer
|
GrantOptions (Right to Buy) · Derivative | 369,256 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000329 · edgar.xml · derivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,256 Underlying: Common Stock · 369,256 shares Expires 2030-05-05 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on May 5, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| May 05, 2020 Filed May 7, 2020 23:53 UTC |
Arumugham RasappaChief Scientific Officer
|
GrantOptions (Right to Buy) · Derivative | 144,766 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000327 · edgar.xml · derivative · entry 1 Arumugham Rasappa · CIK 0001791818 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,766 Underlying: Common Stock · 144,766 shares Expires 2030-05-05 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on May 5, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| May 05, 2020 Filed May 7, 2020 23:50 UTC |
JORGENSEN DANIELChief Medical Officer
|
GrantOptions (Right to Buy) · Derivative | 109,913 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000325 · edgar.xml · derivative · entry 1 JORGENSEN DANIEL · CIK 0001529028 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,913 Underlying: Common Stock · 109,913 shares Expires 2030-05-05 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on May 5, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| May 05, 2020 Filed May 7, 2020 23:46 UTC |
Beck KellyVice President
|
GrantOptions (Right to Buy) · Derivative | 31,916 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000323 · edgar.xml · derivative · entry 1 Beck Kelly · CIK 0001791819 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,916 Underlying: Common Stock · 31,916 shares Expires 2030-05-05 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on May 5, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| May 05, 2020 Filed May 7, 2020 23:44 UTC |
Tammara VijaySenior Vice President
|
GrantOptions (Right to Buy) · Derivative | 20,573 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000321 · edgar.xml · derivative · entry 1 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,573 Underlying: Common Stock · 20,573 shares Expires 2030-05-05 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on May 5, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| April 05, 2020 Filed Apr 8, 2020 20:48 UTC |
Castillo KirstenDirector
|
GrantOption (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001192482-20-000282 · edgar.xml · derivative · entry 1 Castillo Kirsten · CIK 0001808806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2030-04-05 F1 · derivative.exercise_date: The options vest monthly in equal installments over three years commencing on May 5, 2020, subject to continued service with the Company through the applicable vesting dates. Read SEC document |
| April 05, 2020 Filed Apr 8, 2020 20:44 UTC |
Fernandes PrabhavathiDirector
|
GrantOption (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001192482-20-000280 · edgar.xml · derivative · entry 1 Fernandes Prabhavathi · CIK 0001540883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2030-04-05 F1 · derivative.exercise_date: The options vest monthly in equal installments over three years commencing on May 5, 2020, subject to continued service with the Company through the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 20:34 UTC |
Leo FrankDirector
|
GrantOptions (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000020 · edgar.xml · derivative · entry 1 Leo Frank · CIK 0001427325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options vest monthly in equal installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:41 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
GrantOptions (Right to Buy) · Derivative | 933,528 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000027 · edgar.xml · derivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,528 Underlying: Common Stock · 933,528 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on January 2, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:44 UTC |
Beck KellyVice President
|
GrantOptions (Right to Buy) · Derivative | 86,596 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000028 · edgar.xml · derivative · entry 1 Beck Kelly · CIK 0001791819 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,596 Underlying: Common Stock · 86,596 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on January 2, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:40 UTC |
JORGENSEN DANIELChief Medical Officer
|
GrantOptions (Right to Buy) · Derivative | 101,470 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000026 · edgar.xml · derivative · entry 1 JORGENSEN DANIEL · CIK 0001529028 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,470 Underlying: Common Stock · 101,470 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on January 2, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:39 UTC |
Arumugham RasappaChief Scientific Officer
|
GrantOptions (Right to Buy) · Derivative | 111,372 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000025 · edgar.xml · derivative · entry 1 Arumugham Rasappa · CIK 0001791818 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,372 Underlying: Common Stock · 111,372 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on January 2, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:39 UTC |
Tammara VijayVice President
|
GrantOptions (Right to Buy) · Derivative | 77,641 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000024 · edgar.xml · derivative · entry 1 Tammara Vijay · CIK 0001791822 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,641 Underlying: Common Stock · 77,641 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on January 2, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:38 UTC |
Subramanian SanjayChief Financial Officer
|
GrantOptions (Right to Buy) · Derivative | 106,774 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000023 · edgar.xml · derivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,774 Underlying: Common Stock · 106,774 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options will vest annually in equal installments over three years commencing on January 2, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:37 UTC |
Taspolatoglu SuhaDirector
|
GrantOptions (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000022 · edgar.xml · derivative · entry 1 Taspolatoglu Suha · CIK 0001790351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options vest monthly in equal installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:32 UTC |
Potti ManishDirector
|
GrantOptions (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000019 · edgar.xml · derivative · entry 1 Potti Manish · CIK 0001797537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options vest monthly in equal installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:35 UTC |
Zhang JungeDirector
|
GrantOptions (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000021 · edgar.xml · derivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options vest monthly in equal installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:19 UTC |
Kompella UdayDirector
|
GrantOptions (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000018 · edgar.xml · derivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options vest monthly in equal installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:17 UTC |
Kumar RameshDirector
|
GrantOptions (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-20-000017 · edgar.xml · derivative · entry 1 Kumar Ramesh · CIK 0001580074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2030-01-02 F1 · derivative.exercise_date: The options vest monthly in equal installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| December 12, 2019 Filed Dec 14, 2019 01:44 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
PurchaseCommon Stock | 143,000 | $0.35 | $50,050.00 |
DisclosureSEC source: 0001192482-19-000523 · edgar.xml · nonDerivative · entry 2 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,000 F2 · price: Represents the weighted average purchase price of $0.3519. These shares were acquired in multiple transactions ranging from $0.3453 to $0.3602 rounded to the nearest ten-thousandths. The reporting person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 11, 2019 Filed Dec 14, 2019 01:44 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
PurchaseCommon Stock | 263,000 | $0.41 | $107,830.00 |
DisclosureSEC source: 0001192482-19-000523 · edgar.xml · nonDerivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,000 F1 · price: Represents the weighted average purchase price of $0.4056. These shares were acquired in multiple transactions ranging from $0.3815 to $0.4104 rounded to the nearest ten-thousandths. The reporting person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 19:01 UTC |
Zhang JungeDirector
|
PurchaseCommon Stock | 220,000 | $0.44 | $96,800.00 |
DisclosureSEC source: 0001192482-19-000467 · edgar.xml · nonDerivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,578 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.43 to $0.44. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (1) to this Form 4. F2 · balance_after: The amount in Column 5 reflects the deduction of 1,500 shares to correct an error in the reporting person's Forms 4 filed on November 20, 2019, November 26, 2019 and December 2, 2019, in which the number of shares beneficially owned by the reporting person following those dates were over-reported by 1,500 shares. Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 12:37 UTC |
Zhang JungeDirector
|
PurchaseCommon Stock | 270,000 | $0.37 | $99,900.00 |
DisclosureSEC source: 0001192482-19-000449 · edgar.xml · nonDerivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,078 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.36 to $0.38. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 00:18 UTC |
Zhang JungeDirector
|
PurchaseCommon Stock | 115,000 | $0.27 | $31,050.00 |
DisclosureSEC source: 0001192482-19-000447 · edgar.xml · nonDerivative · entry 2 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,078 F2 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.26 to $0.27. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| November 22, 2019 Filed Nov 27, 2019 00:18 UTC |
Zhang JungeDirector
|
PurchaseCommon Stock | 80,000 | $0.28 | $22,400.00 |
DisclosureSEC source: 0001192482-19-000447 · edgar.xml · nonDerivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,078 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.27 to $0.28. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 22, 2019 Filed Nov 27, 2019 00:17 UTC |
Subramanian SanjayChief Financial Officer
|
PurchaseCommon Stock | 5,000 | $0.28 | $1,400.00 |
DisclosureSEC source: 0001192482-19-000445 · edgar.xml · nonDerivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 23:31 UTC |
Zhang JungeDirector
|
PurchaseCommon Stock | 100,000 | $0.41 | $41,000.00 |
DisclosureSEC source: 0001192482-19-000441 · edgar.xml · nonDerivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,078 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.41 to $0.42. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 18, 2019 Filed Dec 5, 2019 00:54 UTC Amendment |
Zhang JungeDirector
|
PurchaseCommon Stock | 98,500 | $0.41 | $40,385.00 |
DisclosureSEC source: 0001192482-19-000465 · edgar.xml · nonDerivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,578 F1 · shares: The reporting person's original Form 4 filed 11/20/2019 reported the purchase of 1,500 shares in excess of the amount actually acquired by the reporting person in the reported transaction, and such additional shares were included in two subsequent Forms 4 filed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.41 to $0.42. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 19:03 UTC |
Zhang JungeDirector
|
PurchaseCommon Stock | 4,000 | $1.48 | $5,920.00 |
DisclosureSEC source: 0001179110-19-010984 · edgar.xml · nonDerivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,078 F1 · price: (1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.47 to $1.50, inclusive. The reporting person undertakes to provide to Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (1) to this Form 4 Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 17:36 UTC |
Subramanian SanjayChief Financial Officer
|
PurchaseCommon Stock | 5,000 | $1.88 | $9,400.00 |
DisclosureSEC source: 0001104659-19-053097 · a4.xml · nonDerivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · price: The option grant has a ten year term and vests in equal installments on the anniversary date over a three year period. Read SEC document |
| October 01, 2019 Filed Oct 4, 2019 17:36 UTC |
Subramanian SanjayChief Financial Officer
|
GrantStock Options · Derivative | 23,970 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001104659-19-053097 · a4.xml · derivative · entry 2 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,970 Underlying: Common Stock · 23,970 shares Expires 2029-10-01 F1 · derivative.exercise_date: The option grant has a ten year term and vests in equal installments on the anniversary date over a three year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.